HomeOpen Access NewsDrug Development

Drug Development

Understanding the true impact of chronic pain

Chronic pain can affect a person’s life in a myriad of ways. Asal Shirazi BEM, Founder of the Autoimmune Support & Awareness Foundation (ASA Foundation), talks us through some of the conditions associated with chronic pain and the advancements in pain management.

ISOTOPICS, a European project for de-risking drug innovation

Christophe Dugave & Karen Hinsinger from CEA-Saclay highlight an exciting European research project for de-risking drug innovation, ISOTOPICS

The changing face of Heterocyclic Chemistry in the pharmaceutical industry

Professor of Organic Chemistry at the University of York and Chairman of the Royal Society of Chemistry’s Heterocyclic and Synthesis Group, Peter O’Brien explores...

IDEAS: improving design, evaluation and analysis of early drug development studies

Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University explores a novel approach to Ph.D. training for those in the pharmaceutical industry

An international approach to the anti-infectives challenge

Professor Colin Suckling from the University of Strathclyde discusses the need for global collaboration on the anti-infectives challenge.

Living with Leukaemia

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is...

Early stage diagnosis – spotting early stage cancer events

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

Treatments and symptoms of Parkinson’s

Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Chemical biology: A chance conversation but an important question

Research professor Prof Colin J Suckling OBE DSc FRSE discusses his engagement with medicinal chemistry and chemical biology

Photodynamic Therapy – radiotherapy for the 21st Century

Photodynamic Therapy is a treatment that combines a photosensitizing drug, visible light and oxygen to kill cancer cells. Professor Eli Glatstein explains

What is the European drug situation in 2017?

Jane Mounteney, Alexis Goosdeel and Paul Griffiths from the EMCDDA highlight key findings from the 2017 European Drug Report and new threats emerging.

Parasitic infection: Animal health matters too

Professor Colin J Suckling explains how teams at the University of Strathclyde and University of Glasgow are challenging global parasitic infection Cows, horse, camels When people...

The evolution of malaria drug development

David H Peyton at Portland State University outlines how research has discovered that heme is key to malaria drug development

Identifying novel biomarkers for drug-induced kidney injury

The European Federation of Pharmaceutical Industries and Associations (EFPIA) explain how SAFE-T DIKI is advancing research into drug-induced kidney injury

Drug development for cancer and inflammatory disease

Sumith A Kularatne, Vice President of Research and Development at On Target Laboratories shares the research strides he has made in drug development

Predicting drug responses

Luminex xTAG® CYP2D6 Kit v3 and xTAG® CYP2C19 Kit v3 assays may aid in determining therapeutic strategies for drugs metabolized by CYP2D6 and CYP2C19...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders